A new insulin-enhancing agent: [N,N′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity

European Journal of Medicinal Chemistry

Volumn 45, Issue 6, 2010, Pages 2327-2335

  Xie, Ming jin ^a   Li, Ling ^b   Yang, Xiao Da ^c   Liu, Wei ping ^d   Yan, Shi ping ^e   Niu, Yan fen ^b   Meng, Zhao hui ^f  

^a YUNNAN UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d KUNMING INSTITUTE OF PRECIOUS METALS   (China)

^e NANKAI UNIVERSITY   (China)

^f Kunming Hospital of Population and Health   (China)

Author keywords

Caco 2 cells; Insulin enhancing; Salen type ligands

Indexed keywords

[N, N' BIS(4 HYDROXYSALICYLIDENE) O PHENYLENEDIAMINE]OXOVANADIUM IV; GLUCOSE; GLYCOGEN; INSULIN; LIPID; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL STRAIN CACO 2; CYTOTOXICITY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DOSE RESPONSE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG PENETRATION; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPHILICITY; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; STREPTOZOCIN DIABETES; WEIGHT REDUCTION; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

ABSORPTION; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CACO-2 CELLS; CELL SURVIVAL; CRYSTALLOGRAPHY, X-RAY; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; GLYCOGEN; HUMANS; INSULIN; LIPIDS; MALE; ORGANOMETALLIC COMPOUNDS; PERMEABILITY; RATS; SPECTRUM ANALYSIS;

EID: 77950865791     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.02.010     Document Type: Article

References (46)

1. Crans D.C., Smee J.J., Gaidamauskas E., and Yang L. Chem. Rev. 104 (2004) 849-902
2. Rehder D. Inorg. Chem. Commun. 6 (2003) 694-697
3. Srivastava A.K., and Mehdi M.Z. Diabet. Med 22 (2004) 2-13
4. Sakurai H., Tsuchiya K., Nukatsuka M., Sofue M., and Kawada J. J. Endocrinol. 126 (1990) 451-459
5. McNeil J.H., Yuen V.G., Hoveyda H.R., and Orvig C. J. Med. Chem. 35 (1992) 1489-1491
6. Yuen V.G., Caravan P., Gelmini L., Glover N., McNeill J.H., Setyawati I.A., Zhou Y., and Orvig C. J. Inorg. Biochem. 68 (1997) 109-116
7. Reul B.A., Amin S.S., Buchet J.-P., Ongemba L.N., Crans D.C., and Brichard S.M. Br. J. Pharmacol. 126 (1999) 467-477
8. Crans D.C., Yang L., Alfano J.A., Chi L.-H., Jin W., Mahroof-Tahir M., Robbins K., Toloue M.M., Chan L.K., Plante A.J., Grayson R.Z., and Willsky G.R. Coord. Chem. Rev. 237 (2003) 13-22
9. Boden G., Chen X., Ruiz J., van Rossum G.D., and Turco S. Metabolism 4 5 (1996) 1130-1135
10. Halberstam M., Cohen N., Shlimovich P., Rossetti L., and Shamoon H. Diabetes 45 (1996) 659-666
11. Goldfine A.K., Patti M.-E., Zuberi L., Goldstein B.J., LeBlanc R., Landaker E.J., Jiang Z.Y., Willsky G.R., and Kahn C.R. Metabolism 49 (2000) 400-410
12. Yuen V.G., Vera E., Battell M.L., Li W.M., and McNeill J.H. Diabetes Res. Clin. Pract. 43 (1999) 9-19
13. Meyerovitch J., Rothenberg P., Shechter Y., Bonner-Weir S., and Kahn C.R. J. Clin. Invest. 87 (1991) 1286-1294
14. Bendayan M., and Gingras D. Diabetologia 32 (1989) 561-567
15. Pederson R.A., Ramanadham S., Buchan A.M., and McNeill J.H. Diabetes 38 (1989) 1390-1395
16. Brichard S.M., Bailey C.J., and Henquin J.-C. Diabetes 39 (1990) 1326-1332
17. Brichard S.M., Pottier A.M., and Henquin J.C. Endocrinology 125 (1989) 2510-2516
18. Thompson K.H., and McNeill J.H. Res. Commun. Chem. Pathol. Pharmacol. 80 (1993) 187-200
19. Dai S., Thompson K.H., and McNeill J.H. Pharmacol. Toxicol. 74 (1994) 101-109
20. Sakurai H., Fujii K., Watanabe H., and Tamura H. Biochem. Biophys. Res. Commun. 214 (1995) 1095-1101
21. Thompson K.H., McNeill J.H., and Orvig C. Chem. Rev. 99 (1999) 2561-2572
22. Yasui H., Tamura A., Takino T., and Sakurai H. J. Inorg. Biochem. 91 (2002) 327-328
23. Fukui K., Fujisawa Y., Ohya-Nishiguchi H., Kamada H., and Sakurai H. J. Inorg. Biochem. 77 (1999) 215-224
24. Orvig C., Thompson K.H., Battell M., and McNeill J.H. Met. Ions Biol. Syst. 31 (1995) 575-594
25. Caravan P., Gelmini L., Glover N., Herring F.G., Li H., McNeill J.H., Rettig S.J., Setyawati I.A., Shuter E., Sun Y., Tracey A.S., Yuen V.G., and Orvig C. J. Am. Chem. Soc. 117 (1995) 12759-12770
26. Yuen V.G., Orvig C., and McNeill J.H. Can. J. Physiol. Pharmacol. 71 (1993) 263-269
27. Thompson K.H., Yuen V.G., McNeill J.H., and Orvig C. Chemical and pharmacological studies of a new class of antidiabetic vanadium complexes. In: Tracey A.S., and Crans D.C. (Eds). Vanadium Compounds. Chemistry, Biochemistry, and Therapeutic Applications. ACS Symposium Series vol. 711 (1998), American Chemical Society, Washington, DC 329-343
28. Thompson K.H., and Orvig C. Dalton Trans. (2006) 761-764
29. Durai N., and Saminathan G. J. Clin. Biochem. Nutr. 22 (1997) 31-39
30. Hidalgo I.J., Raub T.J., and Borchardt R.T. Gastroenterology 96 (1989) 736-749
31. Yamashita S., Furubayashi T., Kataoka M., Sakane T., Sezaki H., and Tokuda H. Eur. J. Pharm. Sci. 10 (2000) 195-204
32. Sheldrick G.M. SHELXS97 and SHELXL97 (1997), University of Gottingen, Germany
33. Sheldrick G.M. SHELXTL. Version 6.10 (2000), Bruker AXS Inc., Madison, Wisconsin, USA
34. Basnet P., Kadota S., Shimizu M., Takata Y., Kobayashi M., and Namba T. Planta Med. 61 (1995) 402-405
35. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., and Cerami A. N. Engl. J. Med. 295 (1976) 417-420
36. Howard B.V., Savage P.J., Bennion L.J., and Bennett P.H. Atherosclerosis 30 (1978) 153-162
37. Nikkila E.A., and Kekki M. Metabolism 22 (1973) 1-22
38. Yang X.G., Yang X.D., Yuan L., Wang K., and Crans D.C. Pharm. Res. 21 (2004) 1026-1033
39. Dodge R.P., Templeton D.H., and Zalkin A. J. Chem. Phys. 35 (1961) 55-67
40. Bruins D., and Weaver D.L. Inorg. Chem. 9 (1970) 130-135
41. Pasquali .M., Marchetti, Floriani C., and Cesari M. Inorg. Chem. 19 (1980) 1198
42. Riley P.E., Pecoraro V.L., Carrano C.J., Bonadies J.A., and Raymond K.N. Inorg. Chem. 25 (1986) 154-160
43. Cornman C.R., Geisre-Bush K.M., Rowley S.R., and Boyle P.D. Inorg. Chem. 36 (1997) 6401-6408
44. Chasteen N.D., Belford R.L., and Paul I.C. Inorg. Chem. 8 (1969) 408-418
45. Ballhausen C.J., and Gray H.B. Inorg. Chem. 1 (1962) 111-122
46. Gao J., Hugger E.D., Bech-Westermeyer M.S., and Borchardt R.T. In: Enna S.J., Williams M., Ferkany J.W., Kenakin T., Porsolt R.D., and Sullivan J.P. (Eds). Current Protocols in Pharmacology (2000), Wiley, New York 7.2.1-7.2.23